12 May 2014

HILTON HOTEL,Toronto May 11-12 Canadian Centre for Applied Research in Cancer Control (ARCC)

ARCC ffices BC Cancer Research Centre (BCCBC), Vancouver & Cancer Care Ontario (CCO),Toronto. Key speaker: NY Memorial Sloane-Kettering Cancer centre Director Health Policy Dr. Peter BACH MD, MAPP(MA in Public Policy). Increasing cost of medicine depends on HIGHER UTILIZATION (Q) and HIGHER PRICES(P) 260 attended. No rep from OMA Board or OMA Policy Staff Cancer drugs now authorized by committees at (CADTH) Ottawa-based "Canadian Agency for Drugs and Technologies in Health." In April 2014 took over pCODR "Pan-Canadian oncology drug review." (For those with private insurance or private means treatment at USA hospitals avoids CADTH delays.

1 comment:

  1. AnonymousMay 12, 2014

    CADTH shows need for personal $250,000 Catastrophic Insurance which gives freedom to chose any hospital worldwide.

    ReplyDelete